Could lowering antipsychotic doses help some schizophrenia patients function better?
NCT ID NCT07152184
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether carefully reducing antipsychotic medication in stable schizophrenia patients can improve their daily functioning compared to staying on the same dose. Researchers will group 288 adults aged 18–60 by their specific psychosis type and randomly assign them to either dose reduction or maintenance. The goal is to find a safer, more personalized way to manage treatment long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYCLOID PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Brain training and exercise from home: a new hope for early schizophrenia?
- Blood inflammation may hold clues to psychiatric diagnosis
- Brain scans probe why social pleasure fades after psychosis
- Can a tailored self-management program improve health outcomes for those with serious mental illness?